MedPath

Comparison of Immediate effect of Integrated Neuromuscular InhibitionTechnique Vs Conventional therapy in individuals with heel pai

Not Applicable
Conditions
Health Condition 1: M709- Unspecified soft tissue disorder related to use, overuse and pressure
Registration Number
CTRI/2023/04/051822
Lead Sponsor
Physiotherapy school and centre TNMC and BYL Charitable Hospital Mumbai Central
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1). 18-60 years of individuals.

2). Both genders.

3). Individuals with active or latent trigger points in gastrosoleus muscle with unilateral

heel pain

4). Individual willing to participant in study and sign the Informed Consent Form.

Exclusion Criteria

1). Individual with vascular conditions (varicose vein, claudication, etc).

2). Individual with recent traumatic history to lower limb.

3). Individual with history of acute ankle sprain.

4). Individual with neurological condition. (UMN/LMN lesion).

5). Individual with radiculopathies or neuropathies in lower limb.

6). Individual with sensory loss over lower limb.

7). Individual with any dermatological condition in lower limb.

8). Any anatomical abnormalities in lower limb.

9). Patient who is unable to understand and follow verbal commands.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1). To assess heel pain intensity using Visual analogue scale (VAS) and ankle passive dorsiflexion range of motion using universal goniometer pre session. <br/ ><br>2). Integrated Neuromuscular Inhibition Technique will be explained to participants and than technique will be performed. <br/ ><br>3). To assess heel pain intensity using VAS and ankle passive dorsiflexion range of motion using universal goniometer post session. <br/ ><br>4). To compared pre session and post session VAS and passive ROM ankle dorsiflexion values between interventional and control group.Timepoint: immediate effect
Secondary Outcome Measures
NameTimeMethod
oneTimepoint: None
© Copyright 2025. All Rights Reserved by MedPath